Oncological Insights from Portuguese Families with Pathogenic Variants in the RAD51 Gene Family
Acta Obstétrica e Ginecológica Portuguesa · 31.12.2025 · 19 (4) · 256-266
DOI: 10.69729/aogp.v19i4a04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstétrica e Ginecológica Portuguesa, online erschienen am 31.12.2025. Verfasst von Gonçalo Freitas und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Overview and Aims: Among populations with hereditary cancer predisposition, gynecological cancers prevention is particularly relevant. Genetic research has highlighted the role of RAD51 gene in maintaining genomic stability and its potential role in cancer susceptibility. Our study aimed to characterize families with pathogenic variants in RAD51 at our center, focusing on the associated clinical outcomes and follow-up care. Study Design: Retrospective study. Population: All families with RAD51 pathogenic variants, followed in our familial cancer risk clinic, at Hospital Dr. Nélio Mendonça, in Madeira Island, from 30-11-2018 to 30-11-2024.
Methods
Data was collected through a review of medical records of all patients who tested positive for RAD51 pathogenic variant, focusing on baseline characteristics and associated neoplasia. We then conducted detailed family analyses to determine specific cancers in affected individuals, linking those variants to oncological outcomes.
Results
Ten index cases with RAD51 pathogenic variants were identified and all of them were female. Indications for test were: breast cancer (4), ovarian cancer (3), fallopian tube carcinoma (1), colorectal cancer (1) and family history (1). The age at breast cancer diagnosis ranged from 36-55 years, and ovarian cancer diagnosis from 52-82 years. Seven different variants were identified: three in the RAD51C gene and four in RAD51D. From subsequent family analysis, we tested a total of 36 individuals and 21 of them tested positive for family mutation. Of those, six had previous history of neoplasia: two ovarian cancers, two breast cancers, one case uterine leiomyosarcoma and one bronchial carcinoid tumor.
Conclusions
These findings highlight the importance of genetic screening and counseling for individuals from high-risk families to enable early detection and management of elevated cancer risks associated with RAD51 pathogenic variants. Prophylactic interventions, such as salpingo-oophorectomy and early cancer screening, are crucial for effectively managing these risks.
Zitieren
APA
Freitas, G., Sargaço, I., Alves, A. S., Câmara, S., Amorim, M., Gaspar, H., & Freitas, R. (2025). Oncological Insights from Portuguese Families with Pathogenic Variants in the RAD51 Gene Family. Acta Obstétrica e Ginecológica Portuguesa, 19(4), 256-266. https://doi.org/10.69729/aogp.v19i4a04
Vancouver
Freitas G, Sargaço I, Alves AS, Câmara S, Amorim M, Gaspar H, et al. Oncological Insights from Portuguese Families with Pathogenic Variants in the RAD51 Gene Family. Acta Obstétrica e Ginecológica Portuguesa. 2025;19(4):256-266. doi:10.69729/aogp.v19i4a04
BibTeX
@article{Freitas2025,
author = {Freitas, Gonçalo and Sargaço, Inês and Alves, Ana Sofia and Câmara, Sara and Amorim, Marta and Gaspar, Hugo and Freitas, Rita},
title = {Oncological Insights from Portuguese Families with Pathogenic Variants in the RAD51 Gene Family},
journal = {Acta Obstétrica e Ginecológica Portuguesa},
year = {2025},
volume = {19},
number = {4},
pages = {256--266},
doi = {10.69729/aogp.v19i4a04}
}
EUVIMED